These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 15662003)
1. Type 2 diabetes-a matter of beta-cell life and death? Rhodes CJ Science; 2005 Jan; 307(5708):380-4. PubMed ID: 15662003 [TBL] [Abstract][Full Text] [Related]
2. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells. Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Dickson LM; Rhodes CJ Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E192-8. PubMed ID: 15271644 [TBL] [Abstract][Full Text] [Related]
5. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Granata R; Settanni F; Gallo D; Trovato L; Biancone L; Cantaluppi V; Nano R; Annunziata M; Campiglia P; Arnoletti E; Ghè C; Volante M; Papotti M; Muccioli G; Ghigo E Diabetes; 2008 Apr; 57(4):967-79. PubMed ID: 18162507 [TBL] [Abstract][Full Text] [Related]
6. IRS proteins and the common path to diabetes. White MF Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E413-22. PubMed ID: 12169433 [TBL] [Abstract][Full Text] [Related]
7. Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention. Karaca M; Magnan C; Kargar C Diabetes Metab; 2009 Apr; 35(2):77-84. PubMed ID: 19251449 [TBL] [Abstract][Full Text] [Related]
8. Insulin signaling in health and disease. White MF Science; 2003 Dec; 302(5651):1710-1. PubMed ID: 14657487 [TBL] [Abstract][Full Text] [Related]
9. Crucial role of insulin receptor substrate-2 in compensatory beta-cell hyperplasia in response to high fat diet-induced insulin resistance. Takamoto I; Terauchi Y; Kubota N; Ohsugi M; Ueki K; Kadowaki T Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():147-56. PubMed ID: 18834442 [TBL] [Abstract][Full Text] [Related]
10. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats. Park S; Hong SM; Sung SR Life Sci; 2008 Feb; 82(9-10):503-11. PubMed ID: 18237751 [TBL] [Abstract][Full Text] [Related]
11. IRS2 takes center stage in the development of type 2 diabetes. Brady MJ J Clin Invest; 2004 Oct; 114(7):886-8. PubMed ID: 15467824 [TBL] [Abstract][Full Text] [Related]
12. Review: pancreatic beta-cell neogenesis revisited. Paris M; Tourrel-Cuzin C; Plachot C; Ktorza A Exp Diabesity Res; 2004; 5(2):111-21. PubMed ID: 15203882 [TBL] [Abstract][Full Text] [Related]
13. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Matveyenko AV; Butler PC Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082 [TBL] [Abstract][Full Text] [Related]
14. The role of mTOR in the adaptation and failure of beta-cells in type 2 diabetes. Leibowitz G; Cerasi E; Ketzinel-Gilad M Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():157-69. PubMed ID: 18834443 [TBL] [Abstract][Full Text] [Related]